Navigation Links
The private sale of drugs in public hospitals
Date:2/8/2010

Governments are under increasing pressure to provide access to expensive new drugs. Canadian patients who want access to drugs that are not publicly insured are seeking to pay for these drugs within public hospitals, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj081137.pdf.

This analysis by Colleen M. Flood, Canada Research Chair in Health Law and Policy, University of Toronto and Lorian Hardcastle, University of Toronto, discusses the debate over whether this policy should change. It looks at the current legislation, policy implications, and a possible Charter challenge.

Every Canadian province has legislation limiting the private sector, which may affect a public hospital's ability to sell drugs.

Those against allowing private payment for drugs in public hospitals suggest this practice would constitute unequal treatment and that it might negatively impact the public system, either by taking clinicians' time away from public patients or by eroding political support for a high standard of care in the public system. Arguments in support of private payment for drugs are centered around safety, access, and liberty.

A patient may successfully claim that these safety concerns violated his or her right to life or security of the person, as set out in the Charter. Government may then have difficulty defending its policy due to a lack of evidence on the negative impact of public hospitals selling insured drugs.

"We conclude that governments should not allow access to uninsured drugs in public hospitals, due to the possible negative effects on the public system," write Lorian Hardcastle, and Colleen Flood.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Page: 1

Related medicine news :

1. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
2. IRIDEX Announces Closing of $5.0 Million Private Placement
3. Inc. Magazine Reveals Its 26th Annual List of Americas 500 Fastest-Growing Private Companies
4. Health Advocate Recognized by Inc. 500 as One of the Nations Fastest Growing Private Companies
5. UNH, state health agency, private industry and NASA to tackle Lyme disease
6. VirtualScopics Announces $4.35 Million Private Placement
7. Largest Privately-Owned Veterinary Practice in the World, Banfield, the Pet Hospital(R), Appoints New Chief Executive Officer
8. New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
9. With the Largest-Ever Buyout of a National Nursing Home Chain Pending ... New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
10. Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance
11. Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered its Serve, Learn, ... school and college students who have participated in the program every summer. The ... now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest ... in two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy ...
(Date:3/29/2017)... ... , ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, is ... or without a referral. Dr. Cotey knows that interceptive orthodontics in Mt. ... patients receive early treatment, they may achieve straight teeth with less treatment in their ...
(Date:3/29/2017)... ... , ... Curio Wellness , a premium medical cannabis brand and trusted ... management team with prominent executives from both inside and outside the cannabis industry. ... Ted Dumbauld , who has more than twenty years of business leadership and investment ...
(Date:3/29/2017)... ... 29, 2017 , ... Immunotherapy has emerged as one of the most promising ... to be the next revolution in our fight against this complex disease. One of ... immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  BioSpecifics Technologies Corp. ... continues to develop collagenase based-therapies with a first ... marketed as XIAFLEX ®  in the U.S. and ... present a corporate overview at the upcoming 16 ... April 5, 2017 at 8:00 a.m. ET in ...
(Date:3/29/2017)... -- Today, CVS Health officials (NYSE: CVS ) ... Public Health Director Gerd Clabaugh and Office of ... the availability of the opioid overdose-reversal medicine naloxone without a ... has established a standing order with physicians in ... to the medication in the state.   "Naloxone ...
(Date:3/29/2017)... -- The Global Health Innovative Technology Fund (GHIT Fund), ... infectious diseases around the globe, today announced 11 ... deliver a range of new innovative therapies for ... This latest round of targeted support includes funding ... pediatric formulation of a drug considered the gold ...
Breaking Medicine Technology: